Curcumin vs Sulforaphane
Two plant-derived anti-inflammatory compounds with a shared problem — real cell-biology mechanisms undermined by how badly the body actually absorbs them.
Curcumin
Turmeric extract
Decent RCT/meta-analysis support for osteoarthritis pain — but curcumin is barely absorbed (hence piperine/formulations) and a textbook PAINS compound that lights up assays deceptively.
Full Curcumin evidence reviewSulforaphane
Broccoli-sprout extract
Genuine human RCTs — but in autism and type-2 diabetes, not aging; the longevity claims rest on the Nrf2 pathway in cells and animals.
Full Sulforaphane evidence reviewSide by side
| Curcumin | Sulforaphane | |
|---|---|---|
| Marketed for | Anti-inflammatory, joint pain | Nrf2 / antioxidant defense, anti-aging |
| Evidence grade | Clinical data | Clinical data |
| Family | mTOR & other | mTOR & other |
| Key human source | Joint-pain meta-analysis, J Med Food 2016 | T2D RCT, Sci Transl Med 2017 |
marks a row where the two differ. Evidence grades come from our evidence matrix, which grades each molecule on the human data for the use it is marketed for.
Our verdict
Curcumin has decent RCT support for joint and arthritis pain, but it's barely absorbed on its own and is a well-known 'PAINS' compound — one that interferes with lab assays in ways that have generated a lot of false-positive research interest. Sulforaphane's Nrf2-activation mechanism is real and well-characterized, with some genuinely positive human trials in specific niches, but 'anti-aging' broadly isn't one of the niches with real data. Both need a real delivery-form check (piperine-enhanced curcumin, myrosinase-active broccoli-sprout extract) before the underlying mechanism has a fair shot at working.
Curcumin fits if
Joint or arthritis-related pain is the specific target, with a bioavailability-enhanced formulation.
Sulforaphane fits if
The Nrf2/detoxification-enzyme mechanism is the interest, understanding the niches with real human data are narrower than general 'anti-aging' marketing implies.